Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467213) titled 'Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Samsung Medical Center
Condition:
Acute Myocardial Infarction (AMI)
Gastrointestinal Bleeding
Intervention:
Drug: Zastaprazan
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: April 1, 2026
Target Sample Size: 5000
To know more, visit https://clinic...